Levofloxacin loaded gelrite-cellulose polymer based sustained ocular drug delivery: formulation, optimization and biological study

被引:10
作者
Aslam, Mohammed [1 ]
Imam, Syed Sarim [2 ]
Aqil, Mohammed [1 ]
Sultana, Yasmin [1 ]
Ali, Asgar [1 ]
机构
[1] Hamdard Univ, Fac Pharm, New Delhi 110062, India
[2] Glocal Univ, Glocal Sch Pharm, Saharanpur 247121, Uttar Pradesh, India
关键词
antimicrobial; gelrite; HET-CAM; levofloxacin; ocular delivery; SITU GELLING SYSTEMS; OPHTHALMIC DELIVERY;
D O I
10.1515/polyeng-2015-0218
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In the present work, levofloxacin in situ gel formulation was developed using gelrite as a gelling agent in combination with hydroxy propyl methyl cellulose. The developed formulations were evaluated for physicochemical parameters, in vitro release, ex vivo transcorneal study, sterility testing, antimicrobial efficacy, ocular irritation study, histopathological and stability evaluation. The in vitro drug release study showed the extended drug release up to 12 h, and the best fit kinetic model was found to be Peppas model (R-2=0.9654), suggesting a Fickian diffusion process. The developed formulations showed optimized physicochemical results for all parameters. The optimized formulation showed therapeutically efficacious antimicrobial activity. Hens egg test-chorioallantoin membrane assay (HET-CAM) showed a mean score of 0.33 up to 24 h, which indicated the non-irritant property of the developed formulation. This non-irritant and stable in situ gel formulation of levofloxacin was found to be promising and safe for use as ocular delivery. The degradation rate constant and shelf life of developed optimized formulation (F14) were found to be low (1.213x10(-4) at 25 degrees C) and 2.14 years, respectively. This renders them favorable for ocular use as they would gel once in contact with the tear fluid, thus reducing nasolacrimal drainage, but would thin upon shearing, preventing ocular irritation and therefore induced lacrimation.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 21 条
[1]  
Abraham S, 2009, PAK J PHARM SCI, V22, P175
[2]   Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Sousa Lobo, Jose Manuel .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (09) :1223-1237
[3]   Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits [J].
Ameeduzzafar ;
Ali, Javed ;
Bhatnagar, Aseem ;
Kumar, Neeraj ;
Ali, Asgar .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 65 :479-491
[4]  
[Anonymous], 2014 16 EUR C POW EL
[5]   Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride [J].
Balasubramaniam, J ;
Pandit, JK .
DRUG DELIVERY, 2003, 10 (03) :185-191
[6]  
Balasubramaniam Jagdish, 2003, Acta Pharmaceutica (Zagreb), V53, P251
[7]   Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system [J].
Gupta, Himanshu ;
Jain, Sanyog ;
Mathur, Rashi ;
Mishra, Pushpa ;
Mishra, Anil K. ;
Velpandian, T. .
DRUG DELIVERY, 2007, 14 (08) :507-515
[8]   Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery [J].
Gupta, Himanshu ;
Aqil, M. ;
Khar, R. K. ;
Ali, Asgar ;
Bhatnagar, Aseem ;
Mittal, Gaurav .
JOURNAL OF DRUG TARGETING, 2011, 19 (06) :409-417
[9]   Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery [J].
Gupta, Himanshu ;
Aqil, Mohammed ;
Khar, Roop K. ;
Ali, Asgar ;
Bhatnagar, Aseem ;
Mittal, Gaurav .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2010, 6 (02) :324-333
[10]   Development and Characterization of 99mTc-timolol Maleate for Evaluating Efficacy of In Situ Ocular Drug Delivery System [J].
Gupta, Himanshu ;
Aqil, M. ;
Khar, R. K. ;
Ali, Asgar ;
Bhatnagar, Aseem ;
Mittal, Gaurav ;
Jain, Sanyog .
AAPS PHARMSCITECH, 2009, 10 (02) :540-546